Main Article Content
The main aim of the study is to focus on the prevalence, prevention and management of anemia and anemia as a comorbidity.
To study the risk factors causing anemia. To educate the patients regarding the problems leading to anemia. To find out proper management of anemia. To examine signs and symptoms, correction of underlying etiology, and prevention of recurrence.
This study is a retrospective observational study that has been conducted over a period of six months. The study was conducted at GLENEAGLES AWARE GLOBAL HOSPITAL, LB NAGAR. The patients who are admitted in the hospital during our study period i.e.; from October 2021 to March 2022 are enrolled. The patients with anemia in presence of many other comorbidities were evaluated, diagnosed, and are prescribed with suitable drug therapy. By using a desirable data collection form, the required details were collected from patient demographics, prescription chart, progress notes, laboratory data, doctor notes, nursing notes, medical records, discharge summary.
One fifty patients were included in the project. The percentage of females with anemia was found to be slightly greater than males i.e. 50.7% females and 49.3% males. Majority of the people with anemia were found to be between the age group of 61-70years (28%). The most common diseases among the sample 150 patients were severe anemia 20% , chronic kidney disease 14.6%, iron deficiency 13.3% etc. The most commonly prescribed medicines are vitamins and minerals 15.01% followed by antibiotics 14.11% followed by antihypertensive agents 10.42%. Age wise distribution of female patients from the sample patients based upon the menstrual cycle where post menstruation women (63.2%) were having less amount of hemoglobin than the menstruating women(28.9%) and pre-menstruation females(7.9%).On comparison of all the comorbidities, severe anemia (20%) followed by chronic kidney disease (14.6%) and iron deficiency anemia (13.3%) were responsible for anemia in majority of population of the sample. Anti-anemic drugs were also prescribed for treatment of anemia. These include erythropoietin stimulation agents (42.8%), Nutraceutical agents (23.8%), and Hematinics (33.3%). Anti-parasitic drugs like metronidazole (83.3%), Ivermectin (8.3%) and Albendazole (8.3%) were prescribed for improving the anemic condition of the patient with parasitic infections. Percentage of patients who received blood transfusions is 28.6% the remaining 71.3% of patients did not receive any blood transfusions.
From our study it has been concluded that anemia is a considerable condition that can affect the therapy of other diseases and can also exaggerate other comorbid diseases equally.